Cardiac Biotech Solutions Inc.
CBSC
Rank in Stocks
#30209
Operating globally through its international subsidiaries, Cardiac Biotech... Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms. These solutions are designed to boost patient engagement for individuals prone to irregular heart rhythms, simultaneously providing medical professionals with highly accurate diagnostic insights. Furthermore, its wholly owned U.S. subsidiary, My-Cardia (USA), Inc., focuses on creating wearable ECG recording devices that patients can utilize in an ambulatory setting for periods extending up to 30 days.
Share Price
$0.0345
Last synced: 2026-11-09
Market Cap
$5.71M
Change (1 day)
-1.43%
Change (1 year)
-9.21%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cardiac Biotech Solutions Inc. (CBSC)
Category
Healthcare
EPS for Cardiac Biotech Solutions Inc. (CBSC)
EPS as of June 2026 TTM: $0.00
According to Cardiac Biotech Solutions Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Cardiac Biotech Solutions Inc. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -56.00% |
| 2025 | $-0.01 | -9.40% |
| 2024 | $-0.01 | -33.90% |
| 2023 | $-0.02 | -74.53% |
| 2022 | $-0.07 | 25.23% |
| 2021 | $-0.06 | 224.56% |
| 2020 | $-0.02 | 1,454.55% |
| 2019 | 0.00 | -94.36% |
| 2018 | $-0.02 | 186.76% |
| 2017 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | -190,327.27% |
US
|
|
| $6.02 | -136,961.36% |
FR
|
|
| $4.15 | -94,418.18% |
US
|
|
| $5.32 | -121,011.36% |
JP
|
|
| $1.29 | -29,418.18% |
CH
|
Questions about Cardiac Biotech Solutions Inc.'s earnings per share (EPS)
What is Cardiac Biotech Solutions Inc.'s earnings per share (EPS)?
Cardiac Biotech Solutions Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was Cardiac Biotech Solutions Inc.'s earnings per share (EPS) in 2025?
In 2025, Cardiac Biotech Solutions Inc.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Cardiac Biotech Solutions Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cardiac Biotech Solutions Inc.'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2022 ($-0.07).
How does Cardiac Biotech Solutions Inc.'s earnings per share (EPS) compare with similar companies?
Cardiac Biotech Solutions Inc.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.